Aurelien M. Vidal

1 Rue Aronnax
Rouez, 44817, France

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 24 publications

Alternative production of Lead-203: Optimizing production, purification, and radiolabelling for enhanced theranostic applications.

Alternative production of Lead-203: Optimizing production, purification, and radiolabelling for enhanced theranostic applications.

Journal: Nuclear medicine and biology
Published: June 19, 2025

Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the 64Cu-Labelling of Immunoconjugates.

Synthesis and In Vitro Comparison of DOTA, NODAGA and 15-5 Macrocycles as Chelators for the 64Cu-Labelling of Immunoconjugates.

Journal: Molecules (Basel, Switzerland)
Published: November 21, 2022

Development of new genetic resources for faba bean (Vicia faba L.) breeding through the discovery of gene-based SNP markers and the construction of a high-density consensus map.

Development of new genetic resources for faba bean (Vicia faba L.) breeding through the discovery of gene-based SNP markers and the construction of a high-density consensus map.

Journal: Scientific reports
Published: March 02, 2020

ARRONAX Cyclotron: Setting up of In-House Hospital Radiopharmacy.

ARRONAX Cyclotron: Setting up of In-House Hospital Radiopharmacy.

Journal: BioMed research international
Published: November 26, 2019

64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study.

64Cu-ATSM/64Cu-Cl2 and their relationship to hypoxia in glioblastoma: a preclinical study.

Journal: EJNMMI research
Published: September 19, 2019

SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human.

SPECT-CT Imaging of Dog Spontaneous Diffuse Large B-Cell Lymphoma Targeting CD22 for the Implementation of a Relevant Preclinical Model for Human.

Journal: Frontiers in oncology
Published: July 11, 2019

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment.

Potential for Nuclear Medicine Therapy for Glioblastoma Treatment.

Journal: Frontiers in pharmacology
Published: January 18, 2019

Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma.

Doxycycline and its quaternary ammonium derivative for adjuvant therapies of chondrosarcoma.

Journal: Cancer chemotherapy and pharmacology
Published: March 28, 2017

Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.

Theranostic Approach for Metastatic Pigmented Melanoma Using ICF15002, a Multimodal Radiotracer for Both PET Imaging and Targeted Radionuclide Therapy.

Journal: Neoplasia (New York, N.Y.)
Published: October 11, 2016

Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept.

Proteoglycans as Target for an Innovative Therapeutic Approach in Chondrosarcoma: Preclinical Proof of Concept.

Journal: Molecular cancer therapeutics
Published: January 09, 2016

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging.

Focus on the Controversial Aspects of (64)Cu-ATSM in Tumoral Hypoxia Mapping by PET Imaging.

Journal: Frontiers in medicine
Published: June 25, 2015

Is there an interest to use deuteron beams to produce non-conventional radionuclides?

Is there an interest to use deuteron beams to produce non-conventional radionuclides?

Journal: Frontiers in medicine
Published: April 10, 2015
Showing 1-12 of 24

Last Updated: 09/26/2026